Your browser doesn't support javascript.
loading
Subjective responses to amphetamine in young adults with previous mood elevation experiences.
Schepers, Scott T; Arndt, David L; Rogers, Robert D; Hedeker, Donald; de Wit, Harriet.
Afiliação
  • Schepers ST; Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 5841 S Maryland Ave, MC3077, Chicago, IL, 60637, USA.
  • Arndt DL; Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 5841 S Maryland Ave, MC3077, Chicago, IL, 60637, USA.
  • Rogers RD; School of Psychology, Bangor University, Gwynedd, Wales, UK.
  • Hedeker D; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.
  • de Wit H; Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 5841 S Maryland Ave, MC3077, Chicago, IL, 60637, USA. hdew@uchicago.edu.
Psychopharmacology (Berl) ; 236(11): 3363-3370, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31209507
ABSTRACT
RATIONALE One risk factor for alcohol and substance misuse is hypomanic experiences, or periods of mood elevation. Young people who report hypomanic states are more likely to develop bipolar disorder (BP), and BP and other mood disorders increase the risk of addiction. We recently reported that young adults with a history of mood elevation experience less subjective effects from a low dose of alcohol, which may be predictive of future alcohol use. The finding with alcohol raised the question of whether this dampened response to a drug also applies to other drugs, such as amphetamine.

OBJECTIVE:

This study assessed responses of d-amphetamine in healthy young adults with varying experiences of mood elevation, as measured by the Mood Disorders Questionnaire (MDQ).

METHODS:

Healthy 18-19-year-olds (N = 30) with a range of MDQ scores participated in three 4-h laboratory sessions in which they received placebo, 10 mg, or 20 mg d-amphetamine. They completed mood questionnaires and cardiovascular measures.

RESULTS:

Individuals with higher MDQ scores reported less stimulation and euphoria after 10 mg, but not 20 mg, d-amphetamine, than individuals with lower scores. MDQ scores were not related to cardiovascular responses to the drug.

CONCLUSIONS:

A history of mood elevation experiences or hypomania states is related to dampened response to a low dose of a psychostimulant drug, extending previous findings with dampened response to alcohol. This phenotype for mood disorders of dampened responses to drugs may contribute to risk for subsequent drug use or misuse.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Comportamento Aditivo / Dextroanfetamina / Euforia / Estimulantes do Sistema Nervoso Central Tipo de estudo: Clinical_trials / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Psychopharmacology (Berl) Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Comportamento Aditivo / Dextroanfetamina / Euforia / Estimulantes do Sistema Nervoso Central Tipo de estudo: Clinical_trials / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Psychopharmacology (Berl) Ano de publicação: 2019 Tipo de documento: Article